Yoo KH - Search Results

1

Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective Studies.

Kang HJ, Hong KT, Lee JW, Kim H, Park KD, Shin HY, Lee SH, Yoo KH, Sung KW, Koo HH, Lee JW, Chung NG, Cho B, Kim HK, Koh KN, Im HJ, Seo JJ, Jung HJ, Park JE, Lee YH, Lim YT, Lim YJ, Kim SY, Yoo ES, Ryu KH, Lee JH, Park JA, Park SK, Ahn HS; Korean Society of Pediatric Hematology-Oncology. Kang HJ, et al. Among authors: yoo es, yoo kh. Biol Blood Marrow Transplant. 2016 Aug;22(8):1455-1459. doi: 10.1016/j.bbmt.2016.04.003. Epub 2016 May 8. Biol Blood Marrow Transplant. 2016. PMID: 27090956 Free article. Clinical Trial.

2

Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: a pilot study in a single center.

Sung KW, Yoo KH, Chung EH, Cho EJ, Jung HL, Koo HH, Lee SK, Lim DH, Kim DY, Kim DW, Kim HR, Kim SW. Sung KW, et al. Among authors: yoo kh. J Korean Med Sci. 2002 Aug;17(4):537-43. doi: 10.3346/jkms.2002.17.4.537. J Korean Med Sci. 2002. PMID: 12172052 Free PMC article. Clinical Trial.

3

Chemoreduction followed by local therapy and adjuvant chemotherapy for advanced intraocular retinoblastoma: a pilot study in a single center.

Yoo KH, Sohn WY, Sung KW, Jung HL, Koo HH, Oh SY, Kang SW. Yoo KH, et al. J Korean Med Sci. 2002 Dec;17(6):817-22. doi: 10.3346/jkms.2002.17.6.817. J Korean Med Sci. 2002. PMID: 12483008 Free PMC article.

4

Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell.

Kim DH, Yoo KH, Choi KS, Choi J, Choi SY, Yang SE, Yang YS, Im HJ, Kim KH, Jung HL, Sung KW, Koo HH. Kim DH, et al. Among authors: yoo kh. Cytokine. 2005 Jul 21;31(2):119-26. doi: 10.1016/j.cyto.2005.04.004. Cytokine. 2005. PMID: 15919213

5

Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.

Shin HY, Kang HJ, Park ES, Choi HS, Ahn HS, Kim SY, Chung NG, Kim HK, Kim SY, Kook H, Hwang TJ, Lee KC, Lee SM, Lee KS, Yoo KH, Koo HH, Lee MJ, Seo JJ, Moon HN, Ghim T, Lyu CJ, Lee WS, Choi YM. Shin HY, et al. Among authors: yoo kh. Pediatr Blood Cancer. 2006 Apr;46(4):439-45. doi: 10.1002/pbc.20555. Pediatr Blood Cancer. 2006. PMID: 16123985 Clinical Trial.

6

Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia.

Choi J, Hwang YK, Sung KW, Kim DH, Yoo KH, Jung HL, Koo HH. Choi J, et al. Among authors: yoo kh. Leuk Res. 2006 Aug;30(8):1019-25. doi: 10.1016/j.leukres.2005.11.001. Epub 2006 Jan 18. Leuk Res. 2006. PMID: 16388850

7

Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.

Jang YK, Jung DH, Jung MH, Kim DH, Yoo KH, Sung KW, Koo HH, Oh W, Yang YS, Yang SE. Jang YK, et al. Among authors: yoo kh. Ann Hematol. 2006 Apr;85(4):212-25. doi: 10.1007/s00277-005-0047-3. Epub 2006 Jan 4. Ann Hematol. 2006. PMID: 16391912

8

Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.

Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, Koo HH, Kim HJ, Kang HJ, Shin HY, Ahn HS. Choi J, et al. Among authors: yoo kh. Blood. 2007 Jan 15;109(2):471-7. doi: 10.1182/blood-2006-07-032557. Epub 2006 Sep 21. Blood. 2007. PMID: 16990595 Free article. Clinical Trial.

9

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT. Sung KW, et al. Among authors: yoo kh. Pediatr Blood Cancer. 2007 Apr;48(4):408-15. doi: 10.1002/pbc.21064. Pediatr Blood Cancer. 2007. PMID: 17066462 Clinical Trial.

10

Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.

Kim DH, Yoo KH, Yim YS, Choi J, Lee SH, Jung HL, Sung KW, Yang SE, Oh WI, Yang YS, Kim SH, Choi SY, Koo HH. Kim DH, et al. Among authors: yoo kh. J Korean Med Sci. 2006 Dec;21(6):1000-4. doi: 10.3346/jkms.2006.21.6.1000. J Korean Med Sci. 2006. PMID: 17179676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,169 results

Search Page

Filters